Primary Care: Clinics in Office Practice 2001: Vol 28 Index

23 Pages·2001·3.7 MB·English

CUMULATIVE INDEX 2001
Volume 28
March EXERCISE TESTING, pages 1-237
June PALLIATIVE CARE, pages 239-458
September GASTROENTEROLOGY, pages 459-683
December IMMUNIZATIONS, pages 685-911
Note: Page numbers of article titles are in boldface type.
Abdominal angina, malabsorption in, Aerobic capacity, in exercise testing, 77-79
515-516 Aerobic fitness, 122-123
Abdominal pain, in irritable bowel Afterload, in exercise, 13
syndrome, 524 Aganglionosis, constipation in, 581
Abetalipoproteinemia, malabsorption in, Age
517 maximal exercise capacity and, 20
Absorption versus vaccine indications, 764-767
anatomy and physiology of, 630-631 Agency for Health Care Policy and
problems with. See Malabsorption. Research pain assessment guidelires,
Achalasia, 468-469 269-277
Acquired immunodeficiency syndrome. See Agitation, in palliative care, 335-336
Human immunodeficiency virus AIDS. See Human immunodeficiency virus
infection. infection.
Adenocarcinoma, esophageal, 475-476, Alcoholism
481-483, 654-656 pancreatitis in, 607-608, 618, 621
Adenomatous polyposis coli, colorectal vaccinations in, 768, 770
cancer in, 663 Altitude, maximal exercise capacity
Adenomatous polyps and, 23
cancer development from, 661-662 American Academy of Pediatrics, palliative
in inflammatory bowel disease, care definition of, 367
547 Aminosalicylates, for inflammatory bowel
Adenosine, for pharmacologic stress disease, 549
testing, 186-187 Amoxicillin, for peptic ulcer disease, 493
Advance directives, 393-394 Amsterdam Criteria, for colorectal cancer
definition of, 350-351 risk, 664
problems with, 351-352 Amylase measurement, in pancreatitis, 601,
prognosis and, 3 609-610
terminology of, 352 Amyotrophic lateral sclerosis, palliative
treatment goals and, 355-358 care in, 354
Adverse reactions, to vaccines. See Vaccines Anaerobic threshold, in exercise, 6, 162,
and vaccination, adverse reactions to; 164-165
Safety, of vaccines. in dyspnea, 167
Advisory Committee on Immunization in heart failure, 168-173
Practices, 700-705 Anemia, in celiac disease, 512
890 CUMULATIVE INDEX
Anesthetics, for palliative care, 290 Autism, measles-mumps-rubella vaccine
Anger, in palliative care, 332 and, 856-859
Angina, abdominal, malabsorption in, Autonomy, as ethical principle, 392
515-516 Azathioprine
Angina pectoris. See Chest pain. for Crohn’s disease, 515
Angiography, in gastrointestinal bleeding, for inflammatory bowel disease, 549-550
569-571
Angioplasty, coronary, exercise testing after,
188, 209-210, 212-214
Animal handling, vaccinations in, 779-780 Bacillus of Calmette and Guerin vaccine, for
Anorectal disorders, constipation in, 582 travelers, 850
Anorexia, in palliative care, 300-301 Bacterial overgrowth syndrome,
Antacids, for gastroesophageal reflux, 479 malabsorption in, 513-514
Anthrax Bad news, 249-267
as biologic warfare agent, 812-815 communication of
treatment of, 815 case study of, 249-250, 256-257
vaccination for, 688, 814 clinical approach to, 256-265
Anti-reflux surgery, for gastroesophageal consensus guidelines for, 255-256
reflux, 480-481 discussion after, 260-261
Antibiotics. See also specific antibiotics. documentation of, 261-262
for inflammatory bowel disease, 550 environment for, 258-259
for pancreatitis, 616-617 family involvement in, 250-253,
- Antibody(ies), Helicobacter pylori, tests for, 263-264
491-492 follow-up plan for, 261
Anticholinergic agents, for irritable bowel literature review on, 250-256
syndrome, 531 opening meeting, 259-260
Antidepressants physicians fear and discomfort with,
for irritable bowel syndrome, 531 253-254
for palliative care, 312-313 randomized controlled studies of,
Antiemetics, for palliative care, 302-304 254-255
Antispasmodic agents, for irritable bowel requests for nondisclosure, 263-264,
syndrome, 531 410
Anxiety self-reflection on, 262
in grief, 419 telephone, 262-263
in palliative care, 310, 323 coping with, continuity in, 264-265
Aortic arch anomalies, esophageal Balke-Ware protocol, for exercise testing,
compression in, 461 42-43
Aortic valve dysfunction, exercise testing Balloon tamponade, of variceal bleeding,
in, 37, 173-174 567
Appetite, in palliative care, 300-301 Banding therapy, for esophageal varices,
Arrhythmias, cardiac. See Cardiac 567-568
arrhythmias. Barium studies
Arterial oxygen content, in exercise, 15 in colorectal cancer screening, 669
Arterial-venous oxygen difference, in in constipation, 584
exercise, 14-15 in dysphagia, 466-467
Asplenia, vaccinations in, 768, 770 in esophageal cancer, 482
Asthma, in gastroesophageal reflux, Barrett esophagus, 473-477, 481
477-478 cancer development in, 475-476
Atherosclerosis, mesenteric, malabsorption definition of, 474
in, 515-516 epidemiology of, 475
Athletes. See also Physical fitness. evaluation of, 476
exercise testing in, 55-61 historical aspects of, 473
Athletic heart syndrome, 56 pathogenesis of, 474-475
Atlanta Symposium, pancreatitis treatment of, 476-477
classification of, 612-613 Basal metabolic equivalents, in exercise
Atrial tachycardia, in exercise testing, 223 testing, 40
Atrioventricular block, exercise testing in, Bayes rule, in exercise testing
35-36 interpretation, 106-110
CUMULATIVE INDEX 891
BCG (Bacillus of Calmette and Guerin Bone, metastasis to, radiation therapy for,
vaccine), for travelers, 850 289
Beliefs, as cross-cultural challenge, 403 Bordetella pertussis infections. See
Beneficence, as ethical principle, 391 Diphtheria-tetanus-acellular pertussis
Bereavemert. See Grief and bereavement. vaccine; Pertussis.
Beta-blockers, for gastrointestinal bleeding, Borreliosis, vaccination for, 849, 873-875
567 Botulinum toxin, for achalasia, 469
Bicycling, in exercise testing, 49, 165-166 Bowel obstruction, in palliative care,
Biliary carcinoma, 656 322-323
Biliary colic, in gallstones, 593, 595 Brain, metastasis to, in palliative care,
Biologic agents, for inflammatory bowel 320-321
disease, 550-551 Breathing, at end of life, 333-334
Biologic warfare agents, 807-821 Brief Pain Inventory, 271-273
countries possessing, 808-811 Brooke ileostomy, for inflammatory bowel
history of, 807-809 disease, 553
in terrorism, 809-811 Bruce protocol, for exercise testing, 40-41,
vaccines for, 811-819 43
anthrax, 812-815 aerobic capacity in, 77-7
plague, 818-819 gas analysis in, 163
smallpox, 815-818 in women, 62-63
Biopsy, small intestine, in malabsorption, Bubonic plague. See Plague.
509-510 Bundle branch block, in exercise testing,
Bismuth subsalicylate, for peptic ulcer 76-77, 224-225
disease, 493
Bisphosphonates, for palliative care,
290
Black death. See Plague. C-reactive protein, measurement of, in
Bleeding pancreatitis, 611
disorders of, vaccinations in, 768-769 Calcium channel blockers, for irritable
gastrointestinal, 557-575 bowel syndrome, 531
assessment of, 558-561 Cancer, 647-660
lower, 568-570 biliary, 656
upper, 561-563 colorectal. See Colorectal cancer.
epidemiology of, 557-558 esophageal, 475-476, 481-483, 654
laboratory tests in, 559-561 gastric, 654-656
lower, 568-571 hospice care in, 656-657
assessment of, 568-570 in celiac disease, 513
treatment of, 571 liver, 656
versus upper, 561 pain assessment in, 276-277
mortality in, 557-558 palliative care in. See Palliative care.
treatment of pancreatic, 651-654
lower, 571 Carbamazepine, for palliative care, 288-289
upper, 563-568 Carbohydrates
upper, 561-568 absorption of, 630
assessment of, 561-563 digestion of, 630
treatment of, 563-568 malabsorption of, 506-507, 509
versus lower, 561 Carbon dioxide, production and
in palliative care, 323, 326 elimination of, in exercise testing,
Bleeding scans, in gastrointestinal bleeding, 161-162
569 Cardiac arrhythmias
Blood pressure, in exercise testing exercise testing in, 172
monitoring of, 45 in exercise testing, 76-77, 220-223
response of, 75-76, 223-224 Cardiac catheterization
Blood transfusions, for gastrointestinal deferral of, in low-risk persons, 112
bleeding, 559 in coronary artery disease, 103-104
Body composition, measurement of, Cardiac disease, vaccinations in, 768, 770
124-127 Cardiac output, in exercise, 6, 9-10
Body mass index, measurement of, 124 venous oxygen content and, 15-16
892 CUMULATIVE INDEX
Cardiac tamponade, in palliative care, Cholestyramine
326 for inflammatory bowel disease, 552
Cardiomyopathy, exercise testing in for irritable bowel syndrome, 531
gas analysis with, 168-171 Chronic illness, palliative care in, 339-347
in athletes, 57 changes occurring in, 340
Cardiopulmonary exercise testing. See Gas chronic obstructive pulmonary disease,
analysis, with exercise testing. 342-343
Cardiopulmonary limits, in exercise, 8-9 congestive heart failure, 341-342
Cardiorespiratory fitness, 122-123 in undefined disease, 345-346
Catheterization, cardiac liver failure, 344-345
deferral of, in low-risk persons, 112 neurodegenerative disease, 345
in coronary artery disease, 103-104 renal disease, 343-344
CBER (Center for Biologics, Evaluation, and resources for, 341
Research), 699-700 versus disease-focused care, 340-341
Celiac disease, 512-513, 633-634 Chronic obstructive pulmonary disease
Celiac plexus block, for pain exercise testing in, 176
in pancreatic cancer, 653-654 palliative care in, 342-343
in pancreatitis, 622 Chronotropic dysfunction, exercise testing
Center for Biologics, Evaluation, and in, 172
Research, 699-700 Chronotropic index, in exercise testing,
Centers for Disease Control and Prevention 74
National Center for Infectious Diseases, Ciprofloxacin
700 for Crohn's disease, 514-515
surveillance activities of, 706 for inflammatory bowel disease, 549
travel medicine information from, Cisapride, for irritable bowel syndrome,
823-824 531-532
vaccine adverse events reporting Clarithromycin, for peptic ulcer disease,
activities, 707 493
Chaplain, in palliative care, 245, 274-275, Clostridium tetani infections, 715
433 Clotting factor deficiency, vaccinations in,
Chemotherapy, for cancer 768-769
esophageal, 654 Codeine, for palliative care, 282
gastric, 656 Cognitive dysfunction, opioid-induced,
metastatic colorectal, 650-651 287-288
pancreatic, 652-653 Cold environment, maximal exercise
Chest pain capacity in, 22-23
exercise testing in, 30 Colectomy
in emergency department, 199-201 for cancer, 649-650
in exercise testing, interpretation of, 76 for constipation, 587-588
risk stratification in, 99-118 for inflammatory bowel disease,
clinical assessment in, 101-103
exercise testing in, 103-116 Colic, biliary, in gallstones, 593, 595
diagnostic, 105-110 Colitis, ulcerative. See Ulcerative colitis.
prognostic, 110-116 Collaborative care, palliative, 243-246,
uses of, 103-105 368-370
principles of, 99-100 College matriculation, vaccinations in,
Chickenpox. See Varicella. 774-775
Children. See also Pediatric patients. Colon
grief in, 420-422 cancer of. See Colorectal cancer.
Chinese herbal medicine, for disorders of, constipation in, 581-582
gastrointestinal disorders, 640-641 diverticula of, bleeding from, 570
Cholecystectomy, for gallstones, 595, inflammatory disease limited to, 542-653
617-618 irritable bowel syndrome of. See Irritable
Cholecystitis, 595-597 bowel syndrome.
Choledocholithiasis, 597-600 polyps of
Cholera, vaccination for, in travelers, 849 cancer development from, 661-662
Cholesterol gallstones, pathogenesis of, in inflammatory bowel disease, 547
591-593 transit studies of, in constipation, 584
CUMULATIVE INDEX 893
Colonoscopy Communication, in palliative care
for bleeding, 568-569 among hospice team, 434
for colorectal cancer, 649, 669 intercultural, 403, 405-406, 408-409
for constipation, 583-584 of bad news, 249-267
for inflammatory bowel disease, 544-548 patient need for, 416-417
for irritable bowel syndrome, 529 verbal versus nonverbal, 405-406
Colorectal cancer, 647-651, 661-674 Compliance, ventricular, in exercise, 11
adenoma-carcinoma sequence in, Compression syndromes, in palliative care,
661-662 318-319
epidemiology of, 647, 661 Computed tomography
hereditary non-polyposis, 664, 671 in gallstones, 594
in inflammatory bowel disease, 547-548 in pancreatitis, 610-611
inherited, 663-664 Conduction disturbances, exercise testing
metastasis from, 650-651 in, 35-36
molecular genetics of, 665 Confusion, in palliative care, 310-312
mortality in, 661 Congenital anomalies, of esophagus,
prevention of, 665-670 460-461
risk factors for, 662-664 Congestive heart failure, palliative care in,
screening for, 648-649, 670-672 341-342
sporadic, 663, 671 Constipation, 524, 577-590
surgery for, 649-650 diagnostic studies of, 583-585
Coma, palliative care in, prognosis for, diary of, 583
354 epidemiology of, 577
Combination vaccines, 739-761 etiology of, 578-582
availability of, 753-754 history of, 582-583
based on diphtheria-tetanus-acellular in irritable bowel syndrome, 524
pertussis vaccine, 741-746 in palliative care, 287, 304-305
DTaP-hepatitis B, 742-746 physical examination in, 583
DTaP-hepatitis B—poliovirus, 742-746 treatment of, 585-588
DTaP-hepatitis B-PRP-tetanus, versus normal physiology, 577-578
745-746 Contractility, in exercise, 12
DTaP-Hib, 741-744 Coping
DTaP-Hib-poliovirus—hepatitis B, with bad news, 264-265
746 with death, ritual in, 405
DTaP-poliovirus, 742-744 Coronary angioplasty, exercise testing after,
DTaP-poliovirus—Hib, 742-744 188, 209-210, 212-214
based on hepatitis B vaccine, 746-747 Coronary artery bypass graft surgery,
hepatitis B—hepatitis A, 747 exercise testing after, 188, 209-212
hepatitis B—Hib, 746 Coronary artery disease
based on Streptococcus pneumoniae exercise testing in, 33-34
vaccine, 749 for risk stratification, 99-118
clinical data on, 741-749 in athletes, 57-58
development of, problems in, 749-750 in elderly persons, 66-70
extra doses of selected components with, in women, 61-66
755 myocardial perfusion imaging with,
history of, 739-741 181-190
importance of, 741 probability of, 88-90
licensed, 739-740 prognostic use of, 90-95
mixing and matching of, 755 with echocardiography, 190-194
MMR-varicella, 747-749 plaque rupture in, 111
premarketing safety studies for, 754 Corticosteroids
public health considerations with, for inflammatory bowel disease, 549
756 for palliative care, 289, 301
reduced immunogenicity of, 752-753 Corynebacterium diphtheriae infection. See
safety of, 751 Diphtheria.
testing of, 750-751 Cough
Common bile duct, stones in in gastroesophageal reflux, 477-478
(choledocholithiasis), 597-600 in palliative care, 306-307
894 CUMULATIVE INDEX
CREST syndrome, esophageal disorders in, Dementia, in palliative care
470 pain assessment in, 277
Crohn’s disease prognosis for, 354
cancer development in, 547-548 Denial, in grief, 418-419
clinical features of, 541 Depression, in palliative care, 312-313
differential diagnosis of, 544 Diabetes mellitus
disease activity index for, 542-543 constipation in, 579
endoscopy in, 545-546 Haemophilus influenzae vaccination and,
etiology of, 539-540 860
extra-intestinal manifestations of, 543 vaccinations in, 768, 770
in pregnancy, 544 Diaphoresis, in palliative care, 336
limited to colon, 542-543 Diaphragm, hiatal hernia of, 462-465, 471
limited to small intestine, 542 Diaries, pain, 273
malabsorption in, 514-515 Diarrhea
measles-mumps-rubella vaccine and, in inflammatory bowel disease, 541
857-858 in irritable bowel syndrome, 524-525,
pathogenesis of, 539-540 530-531
pathology of, 549 in malabsorption, treatment of, 510-511
polyps in, 547 in palliative care, 305-306
pouchitis in, 548 Dicyclomine, for irritable bowel syndrome,
strictures in, 546 531
treatment of, 549-552, 554-555 Diet. See Nutrition.
versus ulcerative colitis, 545-546 Digestion, anatomy and physiology of,
Cryptitis, in inflammatory bowel disease, 505-506, 630-631
548-549 Diphenoxylate, for irritable bowel
Cultural issues, in palliative care, syndrome, 531
401-413 Diphtheria
after death, 337 clinical manifestations of, 713
bad news communication, 253 epidemiology of, 714
communication about, 403 vaccination for, 714-715. See also
context for dying, 402-403 Diphtheria-tetanus-acellular
cross-cultural challenges, 403-405 pertussis vaccine.
definition of culture, 402 age considerations in, 765
explanatory model for, 408 history of, 690
inquiring about practices, 408-409 in pregnancy, 773
negotiating differences, 409-410 in travelers, 828
nutrition decisions, 335 Diphtheria-tetanus-acellular pertussis
physician self-reflection, 407 vaccine, combination vaccines based
verbal versus nonverbal communication, on, 741-746
405-406 DTaP-hepatitis B, 742-746
Culture, of Helicobacter pylori, 491-492 DTaP-hepatitis B—poliovirus, 742-746
Cycle ergometer, in exercise testing, 49, DTaP-hepatitis B-PRP-tetanus, 745-746
165-166 DTaP-Hib, 741-744
Cyclosporine, for inflammatory bowel DTaP-Hib-poliovirus-hepatitis B, 746
disease, 550 DTaP-poliovirus, 742-744
Cystic fibrosis, palliative care in, 382 DTaP-poliovirus—Hib, 742-744
Diphtheria-tetanus-pertussis vaccine,
713-718
Dipyridamole, in pharmacologic stress
Death. See Dying and death. testing, 186-187, 192
Death rattle, 309, 334 Disability, evaluation for, exercise testing in,
Decision-making capacity, ethical issues in, 177, 205-206
392-393 Diverticula
Defecography, in constipation, 584 colonic, bleeding from, 570
Delirium esophageal, 461-462
in palliative care, 310-312, 335-336 Do-not-resuscitate orders, 396-397
opioid-induced, 287-288 Dobutamine, in pharmacologic stress
pain assessment in, 275-276 testing, 186-187, 192
CUMULATIVE INDEX 895
Domperidone, for irritable bowel Electrocardiography, for exercise testing,
syndrome, 532 4446, 49
Double effect principle, in palliative care, Embolism, in palliative care, 326
281, 392 Emergency department, exercise testing in,
Double product, in exercise testing, 75 199-201
Drug(s) Emergent conditions, in palliative care,
abuse of, vaccination recommendations 317-328
for, 781-782 anxiety attack, 323
constipation due to, 580 bowel obstruction, 322-323
exercise testing effects of, 36-37 brain metastasis, 320-321
pancreatitis due to, 608 cardiac tamponade, 326
Dry mouth, in palliative care, 301 compression syndromes, 318-319
DTaP. See Diphtheria-tetanus-acellular dyspnea, 321
pertussis vaccine. embolic phenomena, 326
Duchenne’s muscular dystrophy, palliative hemorrhage, 323, 326
care in, 383-384 hospice kit for, 435
Duplication, esophageal, 461 hypercalcemia, 320
Dying and death, 329-338 nausea and vomiting, 322-325
anger in, 332 panic attack, 323
cultural issues in, 408-409 superior vena cava syndrome, 319
documentation of, 337 urinary tract obstruction, 322
epidemiology of, 429-431 Emphysema, exercise testing in, 176
good, components of, 356 Emporiatrics, vaccinations in. See Travelers,
in pediatric patients, 384-385 vaccinations for.
philosophy of, 329-330 Encephalitis, Japanese, vaccination for,
physical care during, 333-336 838-840
physician responsibilities during, 336-338 Encephalopathy, hepatic, palliative care in,
prognostication of, 331 344-345
realities of, 330-331 End-of-life care. See Palliative care.
ritual involving, 405 Endoscopic retrograde
understanding of, in pediatric patients, cholangiopancreatography
373-374 in cholecystitis, 597
vigil during, 333 in choledocholithiasis, 599
with dignity, 329-330 in pancreatitis, 602, 616, 620
Dyspepsia, in irritable bowel syndrome, Endoscopy. See also Colonoscopy.
525 in dysphagia, 467
Dysphagia, in esophageal disorders, in gastrointestinal bleeding, 562-563
465-467 Endurance, muscular
Dyspnea exercise prescription for, 151-152
exertional, exercise testing in, 166-167 measurement of, 127-132
in palliative care, 307-309, 321 Enema, for constipation, 587
at end of life, 333-334 Energy, for muscular work, in exercise
testing, 5-6
Enteritis, radiation, malabsorption in,
516-517
Echocardiography Environmental factors
stress, 190-194 in maximal exercise capacity, 22-23
with exercise testing, 42 in vaccination requirements, 780-785
after coronary angioplasty, 213-214 Esophageal disorders, 459-485
Ejection fraction, evaluation of, in achalasia, 467-468
radionuclide ventriculography, 189-190 anatomic considerations in, 459-460
Elderly persons Barrett esophagus, 473-477, 481
bacterial overgrowth syndrome in, cancer, 475-476, 481-483, 654
513-514 columnar-lined, with intestinal
Crohn's disease in, 514-515 metaplasia, 476, 481
exercise testing in, 66-70 compression of, in aortic arch anomalies,
palliative care of, opioid administration 461
in, 284 congenital anomalies, 460-461
896 CUMULATIVE INDEX
Esophageal disorders (Continued) after coronary angioplasty, 188, 209-210,
dilatation for, 469-470 212-214
diverticula, 461-462 after coronary artery bypass graft
duplication, 461 surgery, 188, 209-212
dysphagia, 465-467 after myocardial infarction, 173
gastroesophageal reflux, 470-481 after revascularization, 209-217
heterotopic gastric mucosa, 461 alternatives to, 35, 50
hiatal hernia, 462-465, 471 pharmacologic stress testing, 186-187,
lower sphincter relaxation in, 471-472 192
Mallory-Weiss tear, 563-564 cardiopulmonary. See Gas analysis, with
motility, 467-470 exercise testing.
pH monitoring in, 478 complications of, 51
rings, 461 contraindications for, 32, 34-35
scleroderma, 470 current status of, 1-4
spastic, 469-470 cut-off limits of, in myocardial ischemia, 83
stenosis, 460-461 diagnostic, in chest pain, 105-110
structural anomalies, 461-463 drug effects on, 36-37
webs, 461 dynamic, physiologic response in, 18-19
Ethical issues equipment for, 48-50
in gastrostomy placement, for end-of-life evaluation for, 38
feeding, 638 for exercise prescription, 137-158, 177
in palliative care, 391-400 for heart transplantation, 172-173
advance directives and, 393-394 gas analysis with, 77-79, 159-179
decision-making capacity, 392-393 guidelines for, 2
futility of treatment, 394-395 imaging techniques with, 181-198
nutrition, 395-396 gamma camera, 183-186
physician-assisted suicide and myocardial perfusion, 181-190
euthanasia, 397-398 pharmacologic agents in, 186-187
principles of, 391-392 radionuclide ventriculography, 189-190
resuscitation decisions, 396-397 stress echocardiography, 190-194
therapy goals, 358 in aortic stenosis, 37
treatment decisions, 394 in arrhythmias, 172
Ethylmercury, in vaccines, neurologic in athletes, 55-61
effects of, 861-862 in chest pain, risk stratification in, 99-118
Euthanasia, physician-assisted, in chronic extra-cardiac circulatory
397-398 failure, 173-176
Exercise prescription, 137-158, 177 in chronic heart failure, 167-173
components of, 140-141 in chronic pulmonary disorders, 176
definition of, 139-140 in conduction disturbances, 35-36
for flexibility, 153 in coronary artery disease. See Coronary
for muscular strength and endurance, artery disease, exercise testing in.
151-152 in disability evaluation, 177, 205-206
samples of, 146-149 in elderly persons, 66-70
training in in emergency department, 199-201
duration of, 141-142 in exertional dyspnea and fatigue,
frequency of, 141-142 166-167
heart rate calculation for, 143-146 in hypertension, 37, 175-176
intensity of, 141-142 in pulmonary hypertension, 174-175
modes of, 142, 149 in special populations, 55-72
progression of, 150 in special situations, 199-208
resistance, 150-151 in total fitness evaluation, 119-135
Exercise testing in valvular disease, 173-174
abnormal responses to, 219-231 in women, 61-66
arrhythmias, 220-223 indications for, 29-33
bundle branch blocks, 224-225 in athletes, 55-58
hypotension, 223-224 in elderly persons, 66-68
isolated inferior ST depression, 226-230 in women, 61-62
ST elevation, 225-226 risk stratification, 103-105
syncope, 223-224 informed consent for, 39
CUMULATIVE INDEX 897
interpretation of, 73-98 Familial adenomatous polyposis, colorectal
aerobic capacity, 77-79 cancer in, 663, 671
Bayes rule in, 106-110 Family, in palliative care, 244
blood pressure response, 75-76 anger in, 332
cut-off limits and, 83 bad news communication to, 250-253,
diagnostic, 105-110 263-264
dysrhythmias, 76-77 grief in, 415-425
heart rate response, 74-75 in hospice program, 432, 437
in athletes, 58, 60 nondisclosure requests from, 263-264,
in coronary artery disease, 90-95 410
in elderly persons, 68-70 pediatric, 368, 372-375, 385
in myocardial ischemia, 79-88 prognostication, 331
in women, 63-66 support for, 360-361
practical approach to, 88-90 therapy goals and, 358, 360-361
prognostic, 110-116 vigil by, 333
ST segment, 86-87 Fat
symptoms, 76 absorption of, 631
with negative results, 87 body, measurement of, 124-127
modes for, 46-47 digestion of, 630-631
physiologic response in, 17-18 in stool, in pancreatitis, 619-620,
with gas analysis, 162-166 623
monitoring in, 45-46 malabsorption of, 506, 508
negative results in, 87 Fatigue, exertional, exercise testing in,
performance of, 29-53 166-167
physical examination before, 38, 40 Fear, in palliative care, 335-336
physician responsibilities during, 38-48 Fecal occult blood tests, in colorectal cancer
physiology of, 5-28 screening, 667-668
afterload, 13 Feces, fat measurement in, in
cardiopulmonary response, 6-9, 16-17 malabsorption, 508
contractility, 12 Feeding, at end of life, percutaneous
energy for muscular work, 5-6 endoscopic gastrostomy for,
factors influencing, 17-23 636-638
filling pressure, 11 Fentanyl, for palliative care, 282-286
heart rate, 9-10 Fever, in palliative care, 336
in myocardial perfusion imaging, Fiber, dietary
182-183 for colorectal cancer prevention, 666
maximal, 19-23 for constipation, 585
peripheral factors, 14-16 for irritable bowel syndrome, 530
stroke volume, 10-11 Fick principle, 7-8
ventricular compliance, 11 Filling pressure, in exercise, 11
ventricular volume response, 13-14 Fistulas, tracheoesophageal, 460
with gas analysis, 160-162 Fitness. See Physical fitness.
predictive value of, 29-31 Flexibility
preoperative, 177, 201-205 exercise prescription for, 153
preparation for, 44-45 measurement of, 132-133
prognostic, in chest pain, 110-116 Fluid management
protocols for for palliative care
in athletes, 58-60 at end of life, 334-335
in elderly persons, 68 ethical issues in, 395-396
in women, 62-63 for pancreatitis, 615
physiologic response in, 18 5-Fluorouracil, for metastatic colorectal
selection of, 40-43 cancer, 650-651
recovery after, 47-48 Food and Drug Administration
scoring in, 2, 112-114 vaccine activities of, 699, 706-707
static, physiologic response in, 18-19 combination vaccines, 752-754
submaximal, 40-42 vaccine adverse events reporting
supine, physiologic response in, 18 activities, 707
termination of, 47 Frank-Starling mechanism, 11
upright, physiologic response in, 18 Futility, of treatment, 394-395
898 |=C UMULATIVE INDEX
Gabapentin, for palliative care, 288 malabsorption and malnutrition, 505-522,
Gallbladder, inflammation of (cholecystitis), 528
595-597 nutrition. See Nutrition, in
Gallstones, 591-595 gastroenterology.
clinical features of, 593-594 pancreatitis, 607-628
composition of, 592-593 peptic ulcer disease, 487-503, 563
definition of, 591 Gastroesophageal reflux, 470-481
diagnosis of, 594 Barrett esophagus in, 473-477, 481
epidemiology of, 591-592 clinical features of, 470-471
pancreatitis in, 600-603, 607-608 diagnosis of, 478
pathogenesis of, 591-593 extraesophageal manifestations of,
treatment of, 594-595 477-478
Gamma camera, in myocardial perfusion pathophysiology of, 472-473
imaging, with exercise testing, 183-186 treatment of, 478-481
Gardener’s syndrome, colorectal cancer in, Gastrointestinal system, symptoms in, in
663 palliative care, 300-306
Gas analysis, with exercise testing, 159-179 Gastrostomy, percutaneous endoscopic, for
gas monitoring instrumentation in, 166 end-of-life feeding, 636-638
historical background of, 160 Gender, maximal exercise capacity and, 20
in chronic heart failure, 167-173 Genetic factors
in chronic pulmonary disorders, 176 in colorectal cancer, 663-665
in disability evaluation, 177 in inflammatory bowel disease, 539-540
in exercise prescription, 177 in maximal exercise capacity, 20-21
in exertional dyspnea and fatigue, Gluten, avoidance of, in celiac disease,
166-167 633-634
in extra-cardiac circulatory failure, Grief and bereavement, 415-425
173-176 anticipatory, 417
in heart transplantation, 172-173 chronic, 423
in hypertension, 175-176 complicated, 423-424
in myocardial infarction, 173 definitions of, 415
in preoperative risk assessment, 177 delayed, 423
in pulmonary hypertension, 174-175 exaggerated, 423
in valvular disease, 173-174 in children, 420-422
methods for, 162-166 in loss of child, 374-375
physiology of, 160-162 in physicians, 424
Gastrectomy in terminal illness, 415-417
for gastric cancer, 656 interventions for, 417, 420
nutrition after, 634-635 Kubler-Ross stages of, 416
Gastric lavage, for bleeding, 561 manifestations of, 418
Gastric mucosa, heterotopic, in esophagus, masked, 423
461 normal, 418-420
Gastrinoma, peptic ulcer disease in, 497-498 phases of, 418-420
Gastritis, Helicobacter pylori, 489-491 physician’s involvement in, 337
Gastroenteritis Guillain-Barré syndrome, in vaccination,
inflammatory bowel disease after, 540 786
irritable bowel syndrome in, 528
Gastroenterology
bleeding, 557-575
cancer. See Cancer. Haemophilus influenzae infections
cholecystitis, 595-597 clinical manifestations of, 729
choledocholithiasis, 597-600 epidemiology of, 729
constipation, 577-590 vaccination for, 729-731
esophageal disorders. See Esophageal combination
disorders. DTaP-Hib, 741-744
gallstone pancreatitis, 600-603 DTaP-Hib-poliovirus—hepatitis B,
gallstones, 591-595 746
inflammatory bowel disease, 539-556 DTaP-poliovirus—Hib, 742-744
irritable bowel syndrome, 523-538 hepatitis B—Hib, 746